Nathan Becker, M.D.
Opted out of Medicare from January 2016 to January 2028. Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in San Francisco, California, licensed in CA, with an NPI issued in October 2006. Part D covered 4,145 prescriptions written in 2024, 54% of them generic. Abbvie Inc. was the largest of 4 companies reporting payments in 2025, $530.62 in all, mostly food and beverage.
Overview
| NPI | 1972696250 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Oct 1, 2006 |
| Last updated in NPPES | Jul 9, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | C301040 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jan 16, 2016 – Jan 16, 2028 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 4,145 · 9,717 30-day fills |
|---|---|
| Patients | 314 |
| Total drug cost | $780,526 |
| Generic share | 54% of claims |
Industry payments (Open Payments)
- 2025$530.62 · 28 payments from 4 companies
- 2024$667.71 · 28 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbvie Inc. | $187.58 | 14 |
| Lilly USA, LLC | $153.40 | 6 |
| Ibsa Pharma Inc. | $139.06 | 6 |
| Novo Nordisk Inc | $50.58 | 2 |
What the 2025 payments were for
- Food and Beverage$530.62 · 28 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in San Francisco
- 1952868002
- 1760466577
- 1679661656
- 1699059113
- 1821100298
- 1023174877
- 1235322348
- 1376613943
- 1659514412
- 1982312757
- 1932950482
- 1124585393
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →